Issued by Vertex
In this 2020 CR Report, Vertex, a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious disease, shares its progress on: improving the lives of people with serious diseases; fostering an ethical culture that embraces innovation, inclusion, diversity and equity; carefully managing its environmental footprint;, and making a positive impact in the communities where the company is based.
The COVID-19 pandemic and a heightened focus on social and racial justice brought about unprecedented disruption, change and uncertainty. Yet during such a time, Vertex remained steadfast in its mission to innovate and deliver transformative medicines and remained equally committed to supporting its talented workforce and communities.
From responding to the pandemic, building upon its longstanding commitment to inclusion, diversity and equity (ID&E), practicing environmental responsibility and adhering to sustainability best practices in its operations, Vertex really stepped up. All of these achievements are outlined in this 2020 report — the result of many Vertexians coming together with their unique perspectives, fearless pursuit of excellence, collaboration and commitment.
Sarah D’Souza, 617-341-6992
More from Vertex